使使:1

Juanita Lopez1, Thomas Powles2, Fadi Braiteh3

  • 1The Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK. juanita.lopez@icr.ac.uk.

Nature medicine
|January 6, 2025
PubMed
概括

个性化新抗原免疫疗法Autogene cevumeran在71%的晚期癌症患者中表现出良好的耐受性和刺激T细胞反应. 这种方法有望提高癌症免疫疗法的疗效.